NovoCure Limited Ordinary Shares
Symbol: NVCR (NASDAQ)
12.21
▼ (-3.59%) -0.455
Company Description:
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
Key Stats
- Today's Open: $12.54
- Today's High: $13.049
- Today's Low: $11.981
- Today's Volume: 1.48M
- Yesterday Close: $12.66
- Yesterday High: $12.84
- Yesterday Low: $12.4024
- Yesterday Volume: 1.34M
- Last Min Volume: 0
- Last Min High: $12.231
- Last Min Low: $12.205
- Last Min VWAP: $0
Company Profile
- Name: NovoCure Limited Ordinary Shares
- Website: https://www.novocure.com
- Listed Date: 2015-10-02
- Location: ST. HELIER,
- Market Status: Active
- CIK Number: 0001645113
- SIC Code: 3841
- SIC description: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
- Market Cap: $1.41B
- Round Lot: 100
- Outstanding Shares: 111.80M
- Asset Type: CS
RECENT FILINGS FOR NVCR
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 4 | View |
| 2025-08-28 | 8-K | View |
| 2025-08-13 | SCHEDULE 13G | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-07-30 | 4 | View |
| 2025-07-24 | 8-K | View |
| 2025-07-24 | 10-Q | View |
| 2025-07-07 | SCHEDULE 13G/A | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-07-01 | 4 | View |
| 2025-06-30 | S-8 POS | View |
| 2025-06-30 | S-8 POS | View |
| 2025-06-30 | S-8 POS | View |
| 2025-06-30 | S-8 POS | View |
| 2025-06-30 | S-8 POS | View |
| 2025-06-30 | S-8 POS | View |
| 2025-06-30 | S-8 POS | View |
Latest News on NVCR